Maplight Therapeutics, Inc. · NASDAQ:MPLT

Kroeger Christopher A. sold 68,491 Maplight Therapeutics, Inc. shares (Form 4)

Traded May 7 to May 11, 2026 · Filed May 11, 2026

From May 7 to May 11, 2026, Kroeger Christopher A. (Director, Chief Executive Officer) sold 68,491 Maplight Therapeutics, Inc. shares at an average US$28.47 for US$1.95M under a trading plan, leaving 1,512,329 shares. Filed May 11, 2026 (Form 4).

Sold
68,491 shares
Price
US$28.47 average (US$27.48 to US$30.56)
Value
US$1.95M
Holding after
1,512,329 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 7, 2026Voting Common StockSale14,880US$28.471,565,940Direct
May 7, 2026Voting Common StockSale5,220US$29.151,560,720Direct
May 8, 2026Voting Common StockSale29,624US$27.481,531,096Direct
May 8, 2026Voting Common StockSale1,582US$28.561,529,514Direct
May 8, 2026Voting Common StockSale3,205US$29.201,526,309Direct
May 11, 2026Voting Common StockSale342US$27.571,525,967Direct
May 11, 2026Voting Common StockSale877US$28.701,525,090Direct
May 11, 2026Voting Common StockSale6,871US$30.041,518,219Direct
May 11, 2026Voting Common StockSale5,890US$30.561,512,329Direct

Source

View original at SEC

Related